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Iowa Department of Public Health 
Opioid Update: December 2020 
 
The Iowa Department of Public Health (IDPH) offers the Opioid Update to share information 
about opioid use and Iowa’s efforts to address the national opioid epidemic. Please feel free to 
submit topics to RaChel Greenwood at rachel.greenwood@idph.iowa.gov.  
 
In this issue:  
 
● Iowa News 





Opioid Overdose Reversal Kit Promotional Materials Being Sent to Pharmacies 
 
The Iowa Department of Public Health, in collaboration with the Iowa Board of Pharmacy, are 
sending promotional materials regarding the availability of free NARCAN® (the nasal spray 
version of the opioid overdose reversal medication), to the nearly 860 pharmacy locations in 
Iowa. The materials include: 
 Posters 
 Table Tents 
 Stickers 
 Business Cards 
 “Ask-me” Masks 
 Conversation-starter Sheets 
 
This initiative, made possible by the Substance Abuse and Mental Health Services 
Administration (SAMHSA) State Opioid Response grant, is intended to create an awareness 
regarding Narcan availability for eligible individuals. These materials will be followed by an 
upcoming media campaign for the general public that highlights NARCAN® availability 
 
For more information regarding this initiative, please contact Kevin Gabbert, Opioid Initiatives 




People with addiction more likely to get COVID-19 
 
According to the National Institutes of Health, people with a substance use disorder (SUD) were 
over-represented within COVID-19 cases (15.6% of COVID-19 cases but only 10.3% of the 
general population). They were also more likely to experience hospitalization due to COVID-19 
(41% of those with SUD, compared to 30% for those without SUD) and to die from COVID-19 
(9.6% of people with SUD died from COVID-19, vs. 6.6% of those without SUD).  
 
The authors posit that this increased risk of morbidity and mortality from COVID-19 among 
those with SUD is most likely a consequence of both biological and social factors, such as 
 
compromised lungs and cardiovascular systems in people with SUD and the marginalization of 
people with SUD that leads to lower access to health care services.  
 
To read the article about the study, please click this link: NIH 
 
Study Finds 94% of Syringe Service Programs Distribute Naloxone, but Overdose 
Death Rates Call for Scaling Up Efforts 
 
A recent study conducted by a nonprofit research institute found a large increase in the number 
of syringe service programs (SSP’s) distributing naloxone (from 55% in 2013 to 94% in 2020). 
Of the SSP’s that took part in the study, nearly one-third of the programs reported either running 
out of naloxone or needing to ration naloxone in the preceding three months.  
 
As the lead author of the study states, “Syringe service programs have been doing tremendous 
work under difficult circumstances, and we need to be doing more to support these programs to 
scale up naloxone even further.”  
 
To read the article about the study, please click this link: RTI 
 
To read the study findings within the CDC’s Morbidity and Mortality Weekly Report, please click 
on the following link: CDC 
 
Study: Opioid Medication Treatment Combined with Patient Navigation Cost-
Effective for People Released from Jail 
 
An economic analysis on the cost effectiveness of treatment for people with an opioid use 
disorder (OUD) from pre-trial detention in jail through 12 months post-release from jail, found 
that interim methadone treatment while in jail accompanied by patient navigation services post-
release is more cost effective than enhanced treatment-as-usual or interim methadone 
treatment without patient navigation services.   
 
“The financial investment of opioid medication treatment and patient navigation sessions 
beginning in jail and continuing post-release is nominal compared to the benefits measured by 
the reduction in opioid use,” says Gary Zarkin, PhD, lead author of the study.  
 
To read the study abstract, please click this link: IMT 
 
A Decade of Data Tracked the Quality of Addiction Treatment Centers Over Time 
and Across States Using Federal Government’s ‘Signs’ of Higher Quality 
 
The Federal government has encouraged individuals to look for addiction treatment programs 
with characteristics that signal a higher quality of care, such as offering medication assisted 
therapy (MAT) for opioid use disorder (OUD). Through an analysis of a decade (2007-2017) of 
addiction treatment programs across the U.S., researchers found that despite gains from 26% of 
programs offering MAT in 2007 to 40% in 2017, there is much room for improvement and 
significant state-level variation across measures of quality.        
 
To read the article about the study, please click this link: QUAL  
 
Using Real-Time Twitter Data to Track Trends in the Opioid Crisis 
 
 
Opioid Overdose Deaths (OODs) have escalated and evolved through three different phases 
across the country over the last two decades. In 2000, most OODs were related to prescription 
opioids for pain, followed by heroin in 2010 and then synthetic opioid in 2013. Current 
monitoring of OODs relies primarily on mortality data, which often means a 12-18 month 
reporting lag.    
 
A team of researchers examined Twitter data and found that the words used in Twitter posts 
were predictive of the opioid phases for OODs, which suggests that Twitter analysis may be a 
timely surveillance method that can better inform future public health responses in real time.    
 
To read the article about the study, please click this link: OOD 
 
Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity 
and Mortality in the US 
 
A recently published study estimated the future burden of the opioid epidemic and found that the 
opioid epidemic is likely to continue to cause a high number of fatal opioid overdoses in the US 
for at least 10 years. It suggests that an aggressive provision of evidence-based interventions 
may reduce deaths by at least a third. 
 
To read the article about the study, please click this link: JAMA   
 
Opioid prescribing exceeds consumption following common surgical oncology 
procedures 
 
As surgical oncology patients are vulnerable to persistent opioid use, a recent study compared 
the amount of opioids prescribed to those consumed for common surgical oncology procedures 
(e.g. breast biopsy, lumpectomy, or mastectomy) via a telephonic survey. The results suggest 
that opioid prescribing continues to exceed consumption following common surgical oncology 
procedures.     
 
To read the study abstract, please click this link: ONC 
 
Resources 
The International Association for the Study of Pain (IASP) Revised Definition of 
Pain: Concepts, Challenges and Compromises 
 
A multidisciplinary group of experts in the field of pain recently updated the definition of “pain” 
on behalf of the International Association for the Study of Pain and provided a summary of 
findings within an infographic. One of the key objectives of this revision was to support the 
conduct of high quality clinical trials for nonpharmacological approaches for pain and substance 
use disorders informed by the biopsychosocial model of pain.  
 
To download the entire PDF, please click this link: IASP 
 
 
 
